Merck Tbk (Indonesia) Performance
| MERK Stock | IDR 3,580 10.00 0.28% |
The company secures a Beta (Market Risk) of -0.13, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Merck Tbk are expected to decrease at a much lower rate. During the bear market, Merck Tbk is likely to outperform the market. At this point, Merck Tbk has a negative expected return of -0.0912%. Please make sure to verify Merck Tbk's maximum drawdown, potential upside, kurtosis, as well as the relationship between the value at risk and skewness , to decide if Merck Tbk performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Merck Tbk has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent forward-looking signals, Merck Tbk is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors. ...more
| Begin Period Cash Flow | 134.7 B | |
| Total Cashflows From Investing Activities | -43.1 B |
Merck |
Merck Tbk Relative Risk vs. Return Landscape
If you would invest 380,000 in Merck Tbk on September 15, 2024 and sell it today you would lose (22,000) from holding Merck Tbk or give up 5.79% of portfolio value over 90 days. Merck Tbk is generating negative expected returns and assumes 0.8339% volatility on return distribution over the 90 days horizon. Simply put, 7% of stocks are less volatile than Merck, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Merck Tbk Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Merck Tbk's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Merck Tbk, and traders can use it to determine the average amount a Merck Tbk's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1094
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MERK |
Estimated Market Risk
| 0.83 actual daily | 7 93% of assets are more volatile |
Expected Return
| -0.09 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Merck Tbk is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Merck Tbk by adding Merck Tbk to a well-diversified portfolio.
Merck Tbk Fundamentals Growth
Merck Stock prices reflect investors' perceptions of the future prospects and financial health of Merck Tbk, and Merck Tbk fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Merck Stock performance.
| Return On Equity | 0.23 | |||
| Return On Asset | 0.16 | |||
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.21 % | |||
| Current Valuation | 2.02 T | |||
| Shares Outstanding | 448 M | |||
| Price To Earning | 17.23 X | |||
| Price To Book | 2.91 X | |||
| Price To Sales | 1.83 X | |||
| Revenue | 1.06 T | |||
| EBITDA | 203.31 B | |||
| Cash And Equivalents | 164.7 B | |||
| Cash Per Share | 367.64 X | |||
| Total Debt | 13.12 B | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | 1,621 X | |||
| Cash Flow From Operations | 169.81 B | |||
| Earnings Per Share | 365.00 X | |||
| Total Asset | 1.03 T | |||
About Merck Tbk Performance
By examining Merck Tbk's fundamental ratios, stakeholders can obtain critical insights into Merck Tbk's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Merck Tbk is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
PT Merck Tbk manufactures and sells pharmaceutical products in Indonesia. The company was founded in 1970 and is headquartered in East Jakarta, Indonesia. Merck Tbk operates under Drug ManufacturersSpecialty Generic classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 405 people.Things to note about Merck Tbk performance evaluation
Checking the ongoing alerts about Merck Tbk for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Merck Tbk help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Merck Tbk generated a negative expected return over the last 90 days | |
| About 87.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Merck Tbk's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Merck Tbk's stock is overvalued or undervalued compared to its peers.
- Examining Merck Tbk's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Merck Tbk's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Merck Tbk's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Merck Tbk's stock. These opinions can provide insight into Merck Tbk's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Merck Stock
Merck Tbk financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck Tbk security.